Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 263.00 | |
25 mg | In stock | $ 533.00 | |
50 mg | In stock | $ 775.00 | |
100 mg | In stock | $ 1,080.00 | |
500 mg | In stock | $ 2,170.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 178.00 |
Description | AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM. |
Targets&IC50 | DYRK1B:7 nM, DYRK (pS421):0.192 μM |
In vitro | Administration of AZ-Dyrk1B-33 shows inhibition of phosphorylation of Dyrk pS421 in cells with an IC50 of 0.192 μM and no effect in sensitization[1]. |
Synonyms | 3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
Molecular Weight | 300.36 |
Formula | C19H16N4 |
CAS No. | 1679330-37-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (399.52 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZ-Dyrk1B-33 1679330-37-0 Cell Cycle/Checkpoint Tyrosine Kinase/Adaptors DYRK Dual specificity tyrosine regulated kinase kinase syndrome mechanism cells resistance stress inhibit Inhibitor metabolic response undergoing Mirk-related AZDyrk1B33 3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine Minibrain-related Dyrk1B AZ Dyrk1B 33 Dual specificity tyrosine phosphorylation regulated kinase AZ-Dyrk-1B-33 osteosarcoma inhibitor